Table S1 from Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal Metastases

Table S1 from Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal Metastases

<p>Read sequencing depth by sample</p>

Bewaard in:

Bibliografische gegevens
Hoofdauteur:	N. Ari Wijetunga (15056183) (author)
Andere auteurs:	Alexander G. Goglia (15056186) (author), Nils Weinhold (15056189) (author), Michael F. Berger (15048171) (author), Michael Cislo (15056192) (author), Daniel S. Higginson (14949837) (author), Kiana Chabot (15056195) (author), Ahmed M. Osman (15056198) (author), Lauren Schaff (15056201) (author), Elena Pentsova (15056204) (author), Alexandra M. Miller (15056207) (author), Simon N. Powell (15056210) (author), Adrienne Boire (14944705) (author), Jonathan T. Yang (15056213) (author)
Gepubliceerd in:	2025
Onderwerpen:	Cancer Therapeutic Research and Development Methods and Technology CNS Cancers Gene Technologies High-throughput sequencing Liquid Biopsy Radiation Oncology Molecular targets of radiation response Translational Research
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items

Table S2 from Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal Metastases
door: N. Ari Wijetunga (15056183)
Gepubliceerd in: (2025)

Table S3 from Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal Metastases
door: N. Ari Wijetunga (15056183)
Gepubliceerd in: (2025)

Table S4 from Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal Metastases
door: N. Ari Wijetunga (15056183)
Gepubliceerd in: (2025)

Supplementary Data 1 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
door: Francesca Orzan (15055579)
Gepubliceerd in: (2025)

Supplementary Data 2 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
door: Francesca Orzan (15055579)
Gepubliceerd in: (2025)

Supplementary Data 3 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
door: Francesca Orzan (15055579)
Gepubliceerd in: (2025)

Supplementary Figure S1 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
door: Rumani Singh (17141575)
Gepubliceerd in: (2025)

Supplementary Figure S2 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
door: Rumani Singh (17141575)
Gepubliceerd in: (2025)

Supplementary Figure S3 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
door: Rumani Singh (17141575)
Gepubliceerd in: (2025)

Supplementary Figure S4 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
door: Rumani Singh (17141575)
Gepubliceerd in: (2025)

Supplementary Figure S5 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
door: Rumani Singh (17141575)
Gepubliceerd in: (2025)

Supplementary Figure S6 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
door: Rumani Singh (17141575)
Gepubliceerd in: (2025)

Supplementary Table S1 from PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma
door: Mengjie Zhao (14845174)
Gepubliceerd in: (2025)

Supplementary Table S2 from PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma
door: Mengjie Zhao (14845174)
Gepubliceerd in: (2025)

Supplementary Table S4 from PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma
door: Mengjie Zhao (14845174)
Gepubliceerd in: (2025)

Supplementary Table S5 from PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma
door: Mengjie Zhao (14845174)
Gepubliceerd in: (2025)

Supplementary Table S8 from PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma
door: Mengjie Zhao (14845174)
Gepubliceerd in: (2025)

Supplemental Figure 1 from Trimodality Therapy Improves Disease Control in Radiation-Associated Angiosarcoma of the Breast
door: Amy C. Degnim (15106462)
Gepubliceerd in: (2025)

Supplemental Figure 2 from Trimodality Therapy Improves Disease Control in Radiation-Associated Angiosarcoma of the Breast
door: Amy C. Degnim (15106462)
Gepubliceerd in: (2025)

Supplemental Figure 3 from Trimodality Therapy Improves Disease Control in Radiation-Associated Angiosarcoma of the Breast
door: Amy C. Degnim (15106462)
Gepubliceerd in: (2025)

Supplementary Appendix S1 from DNA-Methylome–Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy
door: Bouchra Tawk (15389486)
Gepubliceerd in: (2025)

Figure 1 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
door: Gonzalo Rodriguez-Berriguete (15056057)
Gepubliceerd in: (2025)

Figure 2 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
door: Gonzalo Rodriguez-Berriguete (15056057)
Gepubliceerd in: (2025)

Figure 3 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
door: Gonzalo Rodriguez-Berriguete (15056057)
Gepubliceerd in: (2025)

Figure 4 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
door: Gonzalo Rodriguez-Berriguete (15056057)
Gepubliceerd in: (2025)

Figure 5 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
door: Gonzalo Rodriguez-Berriguete (15056057)
Gepubliceerd in: (2025)

Supplementary Table S1 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
door: Gonzalo Rodriguez-Berriguete (15056057)
Gepubliceerd in: (2025)

Immunohistochemical staining for PHLDA3, APOE, and CPE in irradiated brain tissues.
door: Jing Liu (38537)
Gepubliceerd in: (2025)

Supplementary Table 1 from Monounsaturated and Diunsaturated Fatty Acids Sensitize Cervical Cancer to Radiation Therapy
door: Naoshad Muhammad (14960127)
Gepubliceerd in: (2025)

Supplementary Table 2 from Monounsaturated and Diunsaturated Fatty Acids Sensitize Cervical Cancer to Radiation Therapy
door: Naoshad Muhammad (14960127)
Gepubliceerd in: (2025)

Global Wildfire Brown Carbon Simulation Results: Supporting Data for "Strong Shortwave Absorption by Wildfire Brown Carbon from Global Observations and Modeling"
door: Lulu Xu (21634004)
Gepubliceerd in: (2025)

2024 Meteorological Data, Upper Chesapeake Bay, MarineGEO, Smithsonian Environmental Research Center
door: Sam Benson (17684957)
Gepubliceerd in: (2025)

Supplementary Figure 1 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
door: Michelle L. Mierzwa (14963463)
Gepubliceerd in: (2025)

Supplementary Tables S1-S11 from <i>NBN</i> Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and <i>In Vitro</i> DNA Damage Response Defects
door: Sami Belhadj (15052341)
Gepubliceerd in: (2025)

Supplementary Data 1 from Early Changes in Circulating Cell-Free <i>KRAS</i> G12C Predict Response to Adagrasib in KRAS Mutant Non–Small Cell Lung Cancer Patients
door: Cloud P. Paweletz (14960112)
Gepubliceerd in: (2025)

Supplementary Data 1 from Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer
door: Whitney L. Hensing (16461978)
Gepubliceerd in: (2025)

Supplementary Table S1 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
door: Stephanie Lheureux (16797697)
Gepubliceerd in: (2025)

Supplementary Table S2 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
door: Stephanie Lheureux (16797697)
Gepubliceerd in: (2025)

Supplementary Table S3 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
door: Stephanie Lheureux (16797697)
Gepubliceerd in: (2025)

Supplementary Table S4 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
door: Stephanie Lheureux (16797697)
Gepubliceerd in: (2025)

Cannot write session to /tmp/vufind_sessions/sess_2kv38r2ec9aq2tmi65r7b5prod